ALKERMES | ALKS - 売上総利益





売上総利益 変化する 日付
AbbVie USD 14.8B 411M 2026-09
Acadia Pharmaceuticals USD 307.2M 27.56M 2026-09
ALKERMES USD 303.36M 71.95M 2026-09
Amgen USD 8.46B 1.22B 2026-09
Biogen USD 2.25B 127.8M 2026-09
BioMarin Pharmaceutical USD 719.77M 6.35M 2026-09
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 20.59B 886M 2026-09
Gilead Sciences USD 6.73B 74M 2026-09
Heron Therapeutics USD 29.47M 3.17M 2025-12
Ionis Pharmaceuticals USD 240M 25M 2026-09
J&J USD 18.55B 6M 2026-09
Merck USD 12.21B 121M 2026-06
Minerva Neurosciences -4.27M 26.79M 2024-12
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.06B 125.3M 2026-09
Otsuka Holdings JPY 512.64B 2.41B 2026-09
Pfizer USD 3.24B 3.49B 2026-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Vertex Pharmaceuticals USD 2.94B 99.9M 2026-09